Sponsor:
Washington University School of Medicine
Code:
NCT06040320
Conditions
Post-transplant Lymphoproliferative Disorder
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Polatuzumab vedotin
Rituximab
CHP
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations